Search for Clinical Trial Results

Sponsored By

Non 24 Hour Sleep Wake Disorder - 6 Studies Found

Status Study
Recruiting Study Name: Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Condition: Non 24 Hour Sleep Wake Disorder
Date: 2010-09-28
Interventions: Drug: tasimelteon 20 mg tasimelteon capsules, PO daily for 1 year
Completed Study Name: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Condition: Non-24-Hour Sleep-Wake Disorder
Date: 2011-08-30
Interventions: Drug: tasimelteon 20 mg tasimelteon capsules, PO daily for 24 months + 12 month optional extension
Completed Study Name: Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
Condition:
  • Non-24 Hour Sleep-Wake Disorder
  • Blindness

Date: 2009-09-03
Interventions:
  • Drug: melatonin (Circadin) 2 m
Completed Study Name: Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Condition: Non-24-Hour Sleep-Wake Disorder
Date: 2011-08-30
Interventions:
  • Drug: tasimelteon 20 mg tasime
Completed Study Name: Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Condition: Non-24-Hour Sleep-Wake Disorder
Date: 2010-07-02
Interventions:
  • Drug: tasimelteon 20 mg tasime
Completed Study Name: Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
Condition: Non-24-Hour-Sleep-Wake Disorder
Date: 2014-05-01
Interventions:
  • Drug: tasimelteon 20 mg capsule